Stock Price Quote

TRANSGENE BIOTEK LTD.

NSE : NABSE : 526139ISIN CODE : INE773D01018Industry : Hospital & Healthcare ServicesHouse : Private
BSE4.400.09 (+2.09 %)
PREV CLOSE ( ) 4.31
OPEN PRICE ( ) 4.52
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 23792
TODAY'S LOW / HIGH ( )4.15 4.52
52 WK LOW / HIGH ( ) 3.9111.34
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 01-03 1990
Management Info
K Koteswara Rao - Chairman K Koteswara Rao - Managing Director
Registered Office

Address Plot No. 69 & 70,Anrich Industrial Area,I D A Bollaram Medak Dist,
Bollaram,
Telangana-502325

Phone 040-65589499

Email info@transgenebiotek.com

Website www.transgenebiotek.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE

NEWS

15Nov Transgene Biotek informs about AGM
Transgene Biotek has informed that it attached copies of newspaper adver..
28Jun Transgene Biotek informs about closure
Transgene Biotek has informed that, pursuant to SEBI (Prohibition of Ins..
25Apr Transgene Biotek informs about complia
Transgene Biotek has informed that it enclosed the Compliance Certificat..
01Jan Transgene Biotek informs about outcome
Transgene Biotek has informed that in accordance with the circulars of M..
14Feb Transgene Biotek informs about outcome
With reference to letter dated 27th January 2022, Transgene Biotek has i..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit-0.89-6.55
Gross Profit -0.89 -6.55
Operating Profit -0.49-4.34
Net Sales 0.772.35

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Max Healthcare Inst (BSE)
peergroup  1004.85 (0.40%)
M.Cap ( in Cr)97685.69
Asarfi Hospital Ltd. (BSE)
peergroup  93.63 (1.99%)
M.Cap ( in Cr)184.24
Gian Life Care (BSE)
peergroup  15.50 (2.38%)
M.Cap ( in Cr)16.03
KMC Speciality Hosp (BSE)
peergroup  69.36 (0.23%)
M.Cap ( in Cr)1131.16
Narayana Hrudayalay (BSE)
peergroup  1329.40 (0.01%)
M.Cap ( in Cr)27167.73

Shareholding Pattern

NON-INSTITUTION 76.36%
PROMOTERS 23.64%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Transgene Biotek Ltd.

Transgene Biotek Ltd. was incorporated in the year 1990. Its today's share price is 4.4. Its current market capitalisation stands at Rs 33.34 Cr. In the latest quarter, company has reported Gross Sales of Rs. 2.35 Cr and Total Income of Rs.4.18 Cr. The company's management includes Ankita Jain, Santosh Kumar, Swetha Marri, Sujana Kadiam, K Koteswara Rao, K Koteswara Rao.

It is listed on the BSE with a BSE Code of 526139 , NSE with an NSE Symbol of and ISIN of INE773D01018. It's Registered office is at Plot No. 69 & 70,Anrich Industrial Area,I D A Bollaram Medak DistBollaram-502325, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Gopal & Rajan, Lakshmi & Associates, Manisha Dubey & Associates, Sarath & Associates, Vasavi & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.